ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,616.74
      1.25%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Leap Therapeutics Inc (LPTX)

      7. Leap Therapeutics Inc (LPTX) News

      LPTX

      Leap Therapeutics (LPTX)

      Leap Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LPTX
      DateTimeSourceHeadlineSymbolCompany
      03/02/20184:48PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:LPTXLeap Therapeutics Inc
      02/23/20187:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      02/23/20187:00AMGlobeNewswire Inc.Leap Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Announces Date of its Annual Meeting of Sto...NASDAQ:LPTXLeap Therapeutics Inc
      02/23/20186:54AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:LPTXLeap Therapeutics Inc
      02/14/20185:15PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LPTXLeap Therapeutics Inc
      02/06/20187:00AMGlobeNewswire Inc.Leap Therapeutics to Present at the 20th Annual BIO CEO & Investor ConferenceNASDAQ:LPTXLeap Therapeutics Inc
      01/17/20184:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      01/16/20187:00AMGlobeNewswire Inc.Leap Therapeutics Announces First Patient Dosed with TRX518 Combination Therapy in Advanced Solid Tumors TrialNASDAQ:LPTXLeap Therapeutics Inc
      12/19/201710:10AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LPTXLeap Therapeutics Inc
      12/18/20176:03AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LPTXLeap Therapeutics Inc
      12/15/20174:47PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:LPTXLeap Therapeutics Inc
      12/14/20174:32PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:LPTXLeap Therapeutics Inc
      12/08/20175:06PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:LPTXLeap Therapeutics Inc
      12/08/20174:37PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:LPTXLeap Therapeutics Inc
      11/29/20174:06PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:LPTXLeap Therapeutics Inc
      11/22/20174:13PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LPTXLeap Therapeutics Inc
      11/21/20174:58PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:LPTXLeap Therapeutics Inc
      11/17/20174:33PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      11/16/20174:39PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LPTXLeap Therapeutics Inc
      11/16/20171:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      11/16/20171:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      11/16/20171:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      11/16/20171:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      11/16/20171:43PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:LPTXLeap Therapeutics Inc
      11/15/20177:00AMGlobeNewswire Inc.Leap Therapeutics Announces $18 Million Private Placement OfferingNASDAQ:LPTXLeap Therapeutics Inc
      11/13/20177:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      11/13/20177:00AMGlobeNewswire Inc.Leap Therapeutics Reports Third Quarter 2017 Financial Results and Announces First Patient Dosed with DKN-01 and KEYTRUDA® (...NASDAQ:LPTXLeap Therapeutics Inc
      11/13/20176:55AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LPTXLeap Therapeutics Inc
      09/19/20177:00AMGlobeNewswire Inc.Leap Therapeutics to Present at the 2017 Ladenburg Thalmann Healthcare ConferenceNASDAQ:LPTXLeap Therapeutics Inc
      09/08/20177:00AMGlobeNewswire Inc.Leap Therapeutics Announces Collaboration With EORTC to Evaluate DKN-01 in Combination with PD-L1 Cancer Immunotherapy and Ch...NASDAQ:LPTXLeap Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:LPTX